1
|
Stewart WJ. Tricuspid Regurgitation. JACC Cardiovasc Imaging 2019; 12:443-445. [DOI: 10.1016/j.jcmg.2018.07.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2018] [Revised: 07/27/2018] [Accepted: 07/30/2018] [Indexed: 11/30/2022]
|
2
|
Jarajapu YPR, Grant MB. The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res 2010; 106:854-69. [PMID: 20299675 DOI: 10.1161/circresaha.109.213140] [Citation(s) in RCA: 103] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The discovery of endothelial progenitor cells (EPCs) in human peripheral blood advanced the field of cell-based therapeutics for many pathological conditions. Despite the lack of agreement about the existence and characteristics of EPCs, autologous EPC populations represent a novel treatment option for complications requiring therapeutic revascularization and vascular repair. Patients with diabetic complications represent a population of patients that may benefit from cellular therapy yet their broadly dysfunctional cells may limit the feasibility of this approach. Diabetic EPCs have decreased migratory prowess and reduced proliferative capacity and an altered cytokine/growth factor secretory profile that can accelerate deleterious repair mechanisms rather than support proper vascular repair. Furthermore, the diabetic environment poses additional challenges for the autologous transplantation of cells. The present review is focused on correcting diabetic EPC dysfunction and the challenges involved in the application of cell-based therapies for treatment of diabetic vascular complications. In addition, ex vivo and in vivo functional manipulation(s) of EPCs to overcome these hurdles are discussed.
Collapse
Affiliation(s)
- Yagna P R Jarajapu
- Pharmacology and Therapeutics, College of Medicine, University of Florida, PO Box 100267, Gainesville, FL 32610-0267, USA
| | | |
Collapse
|
3
|
Clinical and functional characterisation of rheumatic mitral regurgitation in children and adolescents including the brain natriuretic peptide. Cardiol Young 2010; 20:66-72. [PMID: 20178681 DOI: 10.1017/s1047951109990941] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Rheumatic fever is a public health problem of universal distribution, predominantly affecting individuals in developing countries. In individuals less than 20 years of age, pure mitral regurgitation is the most commonly found condition in chronic rheumatic valve disease. In the present study, rheumatic mitral regurgitation was assessed in children and adolescents, addressing its clinical (duration of the disease, symptoms, use of benzathine penicillin, and number of outbreaks of the acute phase of rheumatic fever), electrocardiographic (left atrium abnormality and/or left ventricle hypertrophy) and echocardiographic characteristics (left atrium and ventricle measurements, ejection fraction and pulmonary artery pressure), as well as plasma dose of N-terminal portion of the brain natriuretic peptide through electrochemiluminescence immunoassay. Fifty-three patients were studied. The patients had moderate (41.5%) or severe (58.5%) rheumatic mitral regurgitation; had not undergone surgery; were not in the acute phase of the disease; and were being treated at a paediatric cardiology reference hospital in Northeastern Brazil. Mean patient age was 10.6 years (minimum of 3 and maximum of 19 years). With the exception of the ejection fraction, the echocardiographic variables had a significant correlation to the natriuretic peptide, demonstrating that this hormone reflects the haemodynamic consequences of mitral regurgitation. It was concluded that cardiac remodelling that occurs in rheumatic mitral regurgitation in children and adolescents leads to the production of the brain natriuretic peptide, which could be used as a complementary diagnostic tool in the follow-up of such patients.
Collapse
|
4
|
Pizarro R, Bazzino OO, Oberti PF, Falconi M, Achilli F, Arias A, Krauss JG, Cagide AM. Prospective Validation of the Prognostic Usefulness of Brain Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Mitral Regurgitation. J Am Coll Cardiol 2009; 54:1099-106. [PMID: 19744620 DOI: 10.1016/j.jacc.2009.06.013] [Citation(s) in RCA: 107] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2009] [Revised: 05/06/2009] [Accepted: 06/01/2009] [Indexed: 11/18/2022]
Affiliation(s)
- Rodolfo Pizarro
- Cardiology Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Stewart WJ. Criteria for Operative Intervention in Valvular Heart Disease Based on Echocardiography. Echocardiography 2009. [DOI: 10.1007/978-1-84882-293-1_11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
6
|
Affiliation(s)
- Darren K McGuire
- Cardiovascular Division and Donald W. Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, 5909 Harry Hines Blvd, Dallas, TX 75235-9047, USA.
| | | |
Collapse
|
7
|
Vemulapalli S, Metzler SD, Akabani G, Petry NA, Niehaus NJ, Liu X, Patil NH, Greer KL, Jaszczak RJ, Coleman RE, Dong C, Goldschmidt-Clermont PJ, Chin BB. Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT. Radiology 2007; 242:198-207. [PMID: 17185668 DOI: 10.1148/radiol.2421051461] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
PURPOSE To determine the feasibility of in vivo localization and quantification of indium 111 (111In)-oxine-labeled bone marrow (BM) with high-resolution whole-body helical single photon emission computed tomography (SPECT) in an established murine model of atherosclerosis and vascular repair. MATERIALS AND METHODS The institutional animal care and use committee approved this study. BM from young B6 Rosa 26 Lac Z+/+ mice was radiolabeled with 111In-oxine. On days 1, 4, and 7 after administration of radiolabeled cells, five C57/BL6 apolipoprotein E-deficient mice and five wild-type (WT) control mice were imaged with whole-body high-resolution helical SPECT. Quantification with SPECT was compared with ex vivo analysis by means of gamma counting. Autoradiography and beta-galactosidase staining were used to verify donor cell biodistribution. Linear regression was used to assess the correlation between continuous variables. Two-tailed Student t test was used to compare values between groups, and paired two-tailed t test was used to assess changes within subjects at different time points. RESULTS SPECT image contrast was high, with clear visualization of BM, liver, and spleen 7 days after administration of radiolabeled cells. SPECT revealed that 42% and 58% more activity was localized to the aorta and BM (P<.05 for both), respectively, in apolipoprotein E-deficient mice versus WT mice. Furthermore, 28% and 27% less activity was localized to the liver and spleen (P<.05 for both), respectively, in apolipoprotein E-deficient mice versus WT mice. SPECT and organ gamma counts showed good quantitative correlation (r=0.9). beta-Galactosidase staining and microautoradiography of recipient aortas showed donor cell localization to the intima of visible atherosclerotic plaque but not to unaffected regions of the vessel wall. CONCLUSION High-resolution in vivo helical pinhole SPECT can be used to monitor and quantify early biodistribution of 111In-oxine-labeled BM in a murine model of progenitor cell therapy for atherosclerosis.
Collapse
Affiliation(s)
- Sreekanth Vemulapalli
- Department of Medicine, Division of Cardiology, Duke University Medical Center, Box 3808 DUMC, Durham, NC 27710, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Yusoff R, Clayton N, Keevil B, Morris J, Ray S. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation. Am J Cardiol 2006; 97:1498-501. [PMID: 16679092 DOI: 10.1016/j.amjcard.2005.11.085] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2005] [Revised: 11/23/2005] [Accepted: 11/23/2005] [Indexed: 10/24/2022]
Abstract
Plasma levels of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) are elevated in severe mitral regurgitation, but their relation to functional capacity and cardiac remodeling is not well defined. We evaluated the role of NT-pro-BNP as a marker of functional capacity, symptoms, and cardiac remodeling in 38 patients with severe degenerative mitral regurgitation and preserved left ventricular ejection fraction. The NT-pro-BNP levels increased progressively with New York Heart Association (NYHA) functional class: NYHA class I (geometric mean [GM] 97.1 pg/ml), NYHA class II (GM 169.8 pg/ml), and NYHA III (GM 457.6 pg/ml; p = 0.015). The end-systolic volume index (r = 0.52, p = 0.001), end-diastolic volume index (r = 0.46, p = 0.003), left atrial volume index (r = 0.4, p = 0.01), regurgitant volume index (r = 0.38, p = 0.02), regurgitant fraction (r = 0.46, p = 0.003), and end-diastolic sphericity index (r = 0.56, p <0.001) all correlated significantly with NT-pro-BNP. The NT-pro-BNP levels correlated significantly with the exercise parameters: maximum oxygen uptake (r = -0.6, p <0.001), exercise time (r = -0.52, p <0.001), and oxygen pulse (r = -0.57, p <0.001). In contrast, only weak correlations were obtained between the exercise and echocardiographic variables. NT-pro-BNP was a strong independent predictor of maximum oxygen uptake (p = 0.001). In conclusion, the results of this study have demonstrated that NT-pro-BNP increases progressively with worsening symptoms, is linked to the extent of LV remodeling, and is an independent predictor of functional capacity. NT-pro-BNP may have a role in the optimal treatment of patients with severe mitral regurgitation.
Collapse
Affiliation(s)
- Rahal Yusoff
- Department of Cardiology, South Manchester University Hospitals, Wythenshawe, Manchester, United Kingdom.
| | | | | | | | | |
Collapse
|
9
|
Goldschmidt-Clermont PJ, Creager MA, Losordo DW, Lorsordo DW, Lam GKW, Wassef M, Dzau VJ. Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation 2006; 112:3348-53. [PMID: 16301361 DOI: 10.1161/circulationaha.105.577460] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Aziz K. An echocardiographic index for decompensation of the chronically volume-overloaded left ventricle in children. Cardiol Young 2005; 15:589-96. [PMID: 16297252 DOI: 10.1017/s1047951105001757] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/20/2005] [Indexed: 11/06/2022]
Abstract
AIMS The criterions for the timing of surgical intervention in children with rheumatic mitral or aortic valvar regurgitation are not defined. I hypothesized that, in children with chronic mitral or aortic regurgitation, an index for decompensation could be created by using the ratio of the diastolic left ventricular wall thickness to the radius, and that such an index could prove useful in determining the optimal time for surgical intervention. METHODS The left ventricular echocardiograms were obtained at the tips of the leaflets of the mitral valve by M-mode echocardiography. The diastolic septal wall thickness was measured between the right and left ventricular endocardial layers, and the posterior wall thickness between the endocardium and the interphase between the epicardium and the myocardium. The left ventricular diastolic dimension was then measured, between the posterior and septal wall endocardial layers, and systolic dimension as the smallest distance detected between these layers. All diastolic measurements were made at the time of the R wave of electrocardiogram, using the leading edge technique. The ratio of wall thickness was measured using the mean of septal and posterior wall thicknesses divided by half the diastolic dimensions, the normalized thickness of the wall previously referred to as the h/r ratio and relative mural thickness. RESULTS The ratio of wall thickness to left ventricular radius, and its relation to systolic left ventricular pressure or systolic blood pressure, was found to be linear in 89 normal school children, and 39 children with aortic stenosis. For future predictions, I calculated the 95th percentile limits and the 95th percentile confidence bands for this relation. Using the same data, it proved possible to calculate ratios of wall thickness for various ranges of either systolic blood pressure or left ventricular peak pressure. By using the normal limits of 0.356 plus or minus 0.0316 of the ratio, appropriate for the systolic blood pressure of children with mitral regurgitation, I determined the adequacy of the ratio of wall thickness. Of the children, 51 were in ventricular failure, and these had an inadequate ratio, below two standard deviation. Of the others, 21 had an inadequate ratio to within minus one to minus two standard deviations, and 12 of these were asymptomatic, 8 were symptomatic, but only one was in ventricular failure. For 18 children with aortic regurgitation, using the same limits, one child was within 1 standard deviation and was asymptomatic, 8 fell within minus 1 to minus 2 standard deviations and 2 of these were symptomatic, 5 were in ventricular failure, and 1 was asymptomatic, while the other 9 had ratios falling less than minus 2 standard deviations, and all were in ventricular failure. CONCLUSION I conclude that the index of normalized wall thickness defined as the ratio of the left ventricular wall thickness to its radius is adequate, and within normal limits, when there is compensated volume overload, but is inadequate and below normal limits when the volume overloaded left ventricle becomes decompensated. My data suggests that the persistently decreasing ratio of wall thickness below the limits of normality serves as an indicator of ventricular decompensation, and thus can be used as a new criterion for determining the optimal time for surgical intervention.
Collapse
Affiliation(s)
- Kalimuddin Aziz
- Department of Cardiology, National Institute of Cardiovascular Diseases, Karachi, Pakistan.
| |
Collapse
|
11
|
Karra R, Vemullapalli S, Dong C, Herderick EE, Song X, Slosek K, Nevins JR, West M, Goldschmidt-Clermont PJ, Seo D. Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci U S A 2005; 102:16789-94. [PMID: 16275914 PMCID: PMC1277970 DOI: 10.1073/pnas.0507718102] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Atherosclerosis is a chronic inflammatory process and progresses through characteristic morphologic stages. We have shown previously that chronically injecting bone-marrow-derived vascular progenitor cells can effect arterial repair. This repair capacity depends on the age of the injected marrow cells, suggesting a progressive decline in progenitor cell function. We hypothesized that the progression of atherosclerosis coincides with the deteriorating repair capacity of the bone marrow. Here, we ascribe patterns of gene expression that accurately and reproducibly identify specific disease states in murine atherosclerosis. We then use these expression patterns to determine the point in the disease process at which the repair of arteries by competent bone marrow cells ceases to be efficient. We show that the loss of the molecular signature for competent repair is concurrent with the initiation of atherosclerotic lesions. This work provides a previously unreported comprehensive molecular data set using broad-based analysis that links the loss of successful repair with the progression of a chronic illness.
Collapse
Affiliation(s)
- Ravi Karra
- Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC 27705, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Marx N, Wöhrle J, Nusser T, Walcher D, Rinker A, Hombach V, Koenig W, Höher M. Pioglitazone Reduces Neointima Volume After Coronary Stent Implantation. Circulation 2005; 112:2792-8. [PMID: 16246947 DOI: 10.1161/circulationaha.105.535484] [Citation(s) in RCA: 137] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background—
Restenosis requiring reintervention limits the long-term success after coronary stent implantation. Thiazolidinediones, like pioglitazone or rosiglitazone, are oral antidiabetic drugs with additional antirestenotic properties. In a randomized, placebo-controlled, double-blind trial, we examined the effect of 6-month pioglitazone therapy on neointima volume after coronary stenting in nondiabetic coronary artery disease patients.
Methods and Results—
Fifty nondiabetic patients after coronary stent implantation were randomly assigned to pioglitazone (30 mg daily; pio) or placebo (control) treatment in addition to standard therapy, and neointima volume was assessed by intravascular ultrasound at the 6-month follow-up. Both groups were comparable with regard to baseline characteristics, angiographic lesion morphology, target vessel, and length of the stented segment. In addition, there were no statistical differences in minimal lumen diameter before and after intervention, as well as reference diameter after stent implantation. In this study population of nondiabetic patients, pio treatment did not significantly change fasting blood glucose, fasting insulin, or glycosylated hemoglobin levels, as well as lipid parameters. In contrast, pio treatment significantly reduced neointima volume within the stented segment, with 2.3±1.1 mm
3
/mm in the pio group versus 3.1±1.6 mm
3
/mm in controls (
P
=0.04). Total plaque volume (adventitia-lumen area) was significantly lower at follow-up in the pio group (11.2±3.2 mm
3
/mm) compared with controls (13.2±4.2 mm
3
/mm;
P
=0.04). Moreover, the binary restenosis rate was 3.4% in the pio group versus 32.3% in controls (
P
<0.01).
Conclusions—
Thus, 6-month treatment with pio significantly reduced neointima volume after coronary stent implantation in nondiabetic patients. These data bolster the hypothesis that antidiabetic thiazolidinediones, in addition to their metabolic effects, exhibit direct antirestenotic effects in the vasculature.
Collapse
Affiliation(s)
- Nikolaus Marx
- Department of Internal Medicine II, Cardiology, University of Ulm, Ulm, Germany
| | | | | | | | | | | | | | | |
Collapse
|
13
|
|
14
|
Teshima K, Asano K, Sasaki Y, Kato Y, Kutara K, Edamura K, Hasegawa A, Tanaka S. Assessment of Left Ventricular Function Using Pulsed Tissue Doppler Imaging in Healthy Dogs and Dogs with Spontaneous Mitral Regurgitation. J Vet Med Sci 2005; 67:1207-15. [PMID: 16397378 DOI: 10.1292/jvms.67.1207] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Pulsed tissue Doppler imaging (pulsed TDI) has been demonstrated to be useful for the estimation of left ventricular (LV) systolic and diastolic functions in various human cardiac diseases. The objectives of this study were to investigate the relationship between pulsed TDI and LV function by using cardiac catheterization in healthy dogs and to evaluate the clinical usefulness of pulsed TDI in dogs with spontaneous mitral regurgitation (MR). The peak early diastolic velocity (E'), peak atrial systolic velocity (A'), and peak systolic velocity (S') were detectable in the velocity profiles of the mitral annulus in all the dogs. In the healthy dogs, S' and E' were correlated with LV peak +dP/dt and -dP/dt, respectively. E' was lower in dogs with MR than in dogs without cardiac diseases. E/E' in the MR dogs with decompensated heart failure was significantly increased in comparison with those with compensated heart failure. The sensitivity and specificity of the E/E' cutoff value of 13.0 for identifying decompensated heart failure were 80% and 83%, respectively. In addition, E/E' was significantly correlated with the ratio of left atrial to aortic diameter. These findings suggest that canine pulsed TDI can be applied clinically for estimation of cardiac function and detection of cardiac decompensation and left atrial volume overload in dogs with MR.
Collapse
Affiliation(s)
- Kenji Teshima
- Laboratory of Veterinary Surgery, Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University, Fujisawa, Japan
| | | | | | | | | | | | | | | |
Collapse
|
15
|
Tsuda K. Insulin and membrane microviscosity of erythrocytes as risk factors for stroke. Stroke 2003; 34:e225-6; author reply e225-6. [PMID: 14631086 DOI: 10.1161/01.str.0000103353.56177.97] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|